Literature DB >> 9261402

The herpes simplex virus type 1 immediate-early protein ICP0 is necessary for the efficient establishment of latent infection.

C L Wilcox1, R L Smith, R D Everett, D Mysofski.   

Abstract

The immediate-early protein ICP0 of herpes simplex virus type 1 (HSV-1) is not essential for viral replication. However, ICP0 is important for efficient viral replication during the productive infection and for reactivation of latent HSV-1 in vivo. The in vitro model of HSV-1 latency in dorsal root ganglia neurons was used to examine the role of ICP0 in the individual steps that could lead to the appearance of a decreased reactivation phenotype of ICP0 mutant viruses. After establishment of latent infections in the neuronal cultures, induction of reactivation by nerve growth factor (NGF) deprivation resulted in the production of infectious virus with delayed kinetics and a burst size that was significantly decreased for the ICP0 mutants compared with wild-type HSV-1. The efficiency of establishment of latency with the ICP0 mutants was similarly decreased at least 10-fold, as measured by three criteria: (i) the percentage of neurons expressing the major latency-associated transcript during the latent infection, (ii) the amount of viral DNA detected in the neuronal cultures, and (iii) the percentage of neurons expressing ICP4 immunoreactivity after the induction of reactivation. The most striking finding was that ICP0 supplied by an adenovirus vector significantly restored the ability of an ICP0 mutant to establish latency and reactivation. These results strongly indicate a critical role for ICP0 in the establishment of the latent HSV-1 infection in the in vitro neuronal model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261402      PMCID: PMC191958     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro.

Authors:  C L Wilcox; E M Johnson
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.

Authors:  D A Leib; D M Coen; C L Bogard; K A Hicks; D R Yager; D M Knipe; K L Tyler; P A Schaffer
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture.

Authors:  W R Sacks; P A Schaffer
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

4.  Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro.

Authors:  C L Wilcox; E M Johnson
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

5.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans.

Authors:  S Efstathiou; A C Minson; H J Field; J R Anderson; P Wildy
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

6.  Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110.

Authors:  R D Everett
Journal:  J Mol Biol       Date:  1988-07-05       Impact factor: 5.469

7.  Adenovirus vector expressing functional herpes simplex virus ICP0.

Authors:  X X Zhu; C S Young; S Silverstein
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1.

Authors:  R D Everett
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

9.  Alteration of GABAA receptor function following gene transfer of the CLC-2 chloride channel.

Authors:  K Staley; R Smith; J Schaack; C Wilcox; T J Jentsch
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

Review 10.  The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; M A Dalrymple; A J Davison; A Dolan; M C Frame; D McNab; L J Perry; J E Scott; P Taylor
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

View more
  29 in total

1.  Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system.

Authors:  R L Smith; D L Traul; J Schaack; G H Clayton; K J Staley; C L Wilcox
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 renders expression of the immediate-early genes almost entirely dependent on ICP0.

Authors:  K L Mossman; J R Smiley
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 3.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

4.  Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo.

Authors:  R L Thompson; May T Shieh; N M Sawtell
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 5.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

7.  Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression.

Authors:  K R Marshall; R H Lachmann; S Efstathiou; A Rinaldi; C M Preston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage.

Authors:  R Jordan; J Pepe; P A Schaffer
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.

Authors:  Craig S Miller; Robert J Danaher; Robert J Jacob
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.